You are on page 1of 10

List Of References

1) WHO. 10 FACTS ABOUT DIABETES .


http://www.who.int/features/factfiles/diabetes/facts/en/ (accessed October
2013)
2) Powers AC; Harrisons Principles Of InternalMedicine: Diabetes mellitus.
18thedition, New Delhi: McGraw-Hill Companies Inc., 2012.
3) Sarkar A, Dash S, Barik BK, Muttigi MS, Kedage V, Shetty JK et al. Copper
and Ceruloplasmin levels in relation to total thiols and GST in type 2
diabetes mellitus patients. Ind j Clin Biochem 2010; 25:74-76.
4) Alvin CP. Harrisons Principles of Internal Medicine. 16th Edition. McGrawHill; 2005.
5) Sasmita Mishra, P. Padmanaban, G.N. Deepti, G.Sarkar, S. Sumathi, B.D.
Toora. Serum Magnesium and Dyslipidemia in Type-2 Diabetes Mellitus.
http://www.biomedres.info/yahoo_site_admin/assets/docs/295-300Sasmitadoc.100231004.pdf (accessed 2012).
6) Chhabra S, Chhabra S, Ramessur K, Chhabra N. Hypomagnesemia and its
implications in Type 2 Diabetes Mellitus- A Review Article. WebmedCentral
Diabetes 2012;3(12):WMC003878 doi:10.9754/journal.wmc.2012.003878
7) Fort P, Lifshitz F. Magnesium status in children with

insulin-dependent

diabetes mellitus. J Am Coll Nutr 1986;5(1):69-78.


8) Ewald U, Gebre-Medhin M, Turemo T. Hypomagnesemia in diabetic
children. Acta Paediatr Scand 1983;72(3):367-71.
9) Rasheed H, Elahi S, Ajaz H. Serum Magnesium and Atherogenic Lipid
Fractions in Type II Diabetic Patients of Lahore. Pakistan Biol Trace Elem
Res 2012;148(2):165-169.

10)

Mishra S, Padmanaban P, deepti G.N, Sarkar G, Sumathi S, Toora B.D.

Serum

Magnesium

and

Dyslipidemia

in

Type-2

Diabetes

Mellitus.

Biomedical Research 2012; 23 (2): 295-3006


11)

Viktornov A, Toserov E, Krizko M, Durackova Z, Altered metabolism

of copper, zinc, and magnesium is associated with increased levels of


glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009;
58(10):1477-1482.
12)

Dasgupta A, Saikia UK, Sharma D, Saikia M, Dutta Choudhury S.

Quadriparesis in diabetes due to dyselectrolytemia. Indian J Endocrinol


Metab. 2010;14:279.
13)

Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in

patients with type 2 diabetes.Clin J Am Soc Nephrol. 2007;2:36673.


14)

History

of

diabetes

mellitus.

PubMed

NCBI

[Internet].

Ncbi.nlm.nih.gov. 2016 [cited 3 November 2016]. Available from:


https://www.ncbi.nlm.nih.gov/pubmed/11953758.
15)

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of

diabetes-estimates

for

the

year

2000

and

projections

for

2030. Diabetes Care. 2004;27(3):104753.


16)

Whiting Dr, Guariguata L, Weil C, Shawj. IDF Diabetes atlas: Global

estimates of the prevalence of diabetes for 2011 and 2030. Diabetes


Res Clin Pract. 2011; 94:31121.
17)

The Expert Committee on the Diagnosis and Classification of

Diabetes Mellitus: Report of the Expert Committee on the Diagnosis


and Classification of Diabetes Mellitus. Diabetes Care 20: 11831197,
1997.
18)

Diagnosis and classification of diabetes mellitus. Diabetes Care.

2010 Jan. 33 Suppl 1:S62-9.

19)

The Expert Committee on the Diagnosis and Classification of

Diabetes Mellitus: Follow-up report on the diagnosis of diabetes


mellitus. Diabetes Care 26: 31603167, 2003.
20)

Diabetes

Symptoms,

eMedicineHealth.

2016

Diet,
[cited

Tests
3

&

Treatment

[Internet].

November2016].Availablefrom:

http://www.emedicinehealth.com/diabetes_mellitus_type_1_and_type_2
/article_em.htm.
21)

Recognizing Type 2 Diabetes Symptoms [Internet]. Healthline. 2016

[cited

November

2016].

Available

from:

http://www.healthline.com/health/type-2-diabetes/recognizingsymptoms#Overview1.
22)

Type 2 Diabetes Complications [Internet]. EndocrineWeb. 2016

[cited

November

2016].

Available

from:

http://www.endocrineweb.com/conditions/type-2-diabetes/type-2diabetes-complications.
23)

Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated

macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes


Metab. 2007;9:767780.
24)

Buyken AE, von Eckardstein A, Schulte H, et al. Type 2 diabetes

mellitus and risk of coronary heart disease: results of the 10-year


follow-up of the PROCAM Study. Eur J Cardiovasc Prev Rehabil.
2007;14:230236.
25)

Bonora E, Formentini G, Calcaterra F, et al. HOMA-estimated insulin

resistance is an independent predictor of cardiovascular disease in type


2 diabetic subjects: prospective data from the Verona Diabetes
Complications Study. Diabetes Care. 2002;25:11351141.
26)

Kullo IJ, Bailey KR, Kardia SL, et al. Ethnic differences in peripheral

arterial disease in the NHLBI Genetic Epidemiology Network of


Arteriopathy (GENOA) Study. Vasc Med. 2003;8:237242.

27)

Schainfeld RM. Management of peripheral arterial disease and

intermittent claudication. J Am Board Fam Pract. 2001;14:443450.


28)

Abbott RD, Curb JD, Rodriguez BL, et al. Age-related changes in risk

factor effects on the incidence of thromboembolic and hemorrhagic


stroke. J Clin Epidemiol. 2003;56:479486.
29)

Ohira T, Shahar E, Chambless LE, et al. Risk factors for ischemic

stroke subtypes: the Atherosclerosis Risk in Communities Study. Stroke.


2006;37:24932498.
30)

Haheim LL, Holme I, Hjermann I, Leren P. Nonfasting serum glucose

and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year
follow-up of the Oslo Study. Stroke. 1995;26:774777.
31)

Drummond K, Mauer M. The early natural history of nephropathy in

type 1 diabetes, II: early renal structural changes in type 1 diabetes.


Diabetes. 2002;51:15801587.
32)

Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on

renal and cardiovascular outcomes in patients with type 2 diabetes and


nephropathy. N Engl J Med. 2001;345:861869.
33)

World

Health

Organization.

Diabetes

facts.

Available

at:

http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
Accessed December 13, 2007.
34)

Harding S. Extracts from concise clinical evidence: diabetic

retinopathy. BMJ. 2003;326:10231025.


35)

Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged

severity of various types of diabetic neuropathy, retinopathy, and


nephropathy in a population-based cohort: the Rochester Diabetic
Neuropathy Study. Neurology. 1993;43:817824.
36)

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic

neuropathy. Diabetes Care. 2003;26:15531579.

37)

WHO | Diabetes mellitus [Internet]. Who.int. 2016 [cited 3

November

2016].

Available

from:

http://www.who.int/mediacentre/factsheets/fs138/en/.
38)

The Importance of Magnesium in the Human Body: A Systematic

Literature Review. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2016


[cited

November

2016].

Available

from:

https://www.ncbi.nlm.nih.gov/pubmed/26975973.
39)

Cotton FA, Wilkinson G. Weilheim, Germany: Chemie GmbH; 1967.

Anorganische Chemie.
40)

Fox C, Ramsoomair D, Carter C. Magnesium: its proven and

potential clinical significance. South Med J 2001;94:1195-1201.


41)

Aikawa JK. Magnesium: Its Biological Significance. Boca Raton, FL:

CRC Press; 1981.


42)

Maguire ME, Cowan JA. Magnesium chemistry and biochemistry.

Biometals 2002;15:203-210.
43)

Alfrey AC, Miller NL. Bone magnesium pools in uremia. J Clin Invest

1973;52:3019-3027.
44)

Touyz

RM.

Magnesium

in

clinical

medicine.

Front

Biosci

2004;9:1278-1293.
45)

Elin RJ. Magnesium metabolism in health and disease. Dis Mon

1988;34:161-218.
46)

Shechter M, Merz CN, Paul-Labrador M, et al. Oral magnesium

supplementation inhibits platelet-dependent thrombosis in patients


with coronary artery disease. Am J Cardiol 1999;84:152-156.
47)
Cunningham J, Rodrguez JM, Messa P. Magnesium in chronic kidney
disease stages 3 and 4, and in dialysis patients. Clin Kidney J
2012;5(Suppl 1):i39-i51.

48)

Aikawa JK. Magnesium: Its Biological Significance. Boca Raton, FL:

CRC Press; 1981.


49)

Saris NE, Mervaala E, Karppanen H, et al. An update on

physiological,

clinical

and

analytical

aspects.

Clin

Chim

Acta

2000;294:1-26.
50)

de Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium

balance: lessons learned from human genetic disease. Clin Kidney J


2012;5(Suppl 1):i15-i24.
51)

Rude R. Magnesium disorders. In: Kokko J, Tannen R (eds). Fluids

and electrolytes. Philadelphia, PA: W.B. Saunders Company, 1996, pp.


421445.
52)

Dirks JH. The kidney and magnesium regulation. Kidney Int

1983;23:771-777.
53)

Quamme GA, Dirks JH. The physiology of renal magnesium

handling. Ren Physiol 1986;9:257-269.


54)

Swaminathan R. Magnesium metabolism and its disorders. Clin

Biochem Rev 2003;24:47-66.


55)

Wacker W. Magnesium and Man. Cambridge, MA: Havard University

Press; 1980. p. 1-184.


56)

Hashizume N, Mori M. An analysis of hypermagnesemia and

hypomagnesemia. Jpn J Med 1990;29:368-372.


57)

Durlach J and Altura BM. Magnesium, diabetes and carbohydrate

metabolism. Magnesium 2. 1983; 173-336.


58)

Lecube A, Baena-Fustegueras JA, Fort JM, Pelegr D, Hernndez C.

Diabetes is the main factor accounting for hypomagnesemia in obese


subjects. PLoS One. 2012; 7: e30599.
59)
Grafton G, Bunce CM, Sheppard MC, Brown G, Baxter MA. Effect of
Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology
of diabetic complications. Diabetes. 1992; 41: 35-39.

60)

Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL . Serum and dietary

magnesium

and

the

risk

for

type

diabetes

mellitus:

the

Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999; 159:


2151-2159.
61)

Van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary

calcium and magnesium, major food sources, and risk of type 2


diabetes in U.S. black women. Diabetes Care. 2006; 29: 2238-2243.
62)

Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC. Diet and

risk of clinical diabetes in women. Am J Clin Nutr. 1992; 55: 1018-1023.


63)

Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2

diabetes mellitus, metabolic syndrome and insulin resistance. Arch


Biochem Biophys. 2007; 458: 40-47.
64)

Martha RM and Fernando GR. Oral Magnesium Supplementation

Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic


Subjects A randomized double-blind controlled trial Diabetes Care
2003; 26: 1147-1152.
65)

Lucy D, Anoja SA and Chun-SY. Alternative Therapies for Type 2

Diabetes. Alternative Medicine Review 2002; 7: 45-48.


66)

Mather

HM,

Nisbet

JA,

Burton

GH,

Poston

GJ,

Bland

JM.

Hypomagnesaemia in diabetes. Clin Chim Acta. 1979; 95: 235-242.


67)

Ashima Badyal, Kuldip Singh Sodhi, Rajesh Pandey, Jasbir Singh,

Serum Magnesium Levels: A Key Issue For Diabetes Mellitus, 2011; 13


(3), 132-34.
68)

Wlti MK, Zimmermann MB, Walczyk T, Spinas GA, Hurrell RF.

Measurement of magnesium absorption and retention in type 2


diabetic patients with the use of stable isotopes. Am J Clin Nutr.
2003;78:448453.
69)
Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L,
Pineo A, Busardo A, Paolisso G. Role of magnesium in insulin action,
diabetes

and

2003;24:3952.

cardio-metabolic

syndrome

X.

Mol

Aspects

Med.

70)

Djurhuus MS, Sktt P, Hother-Nielson O, Klitgaard NA, Beck-Nielsen

H. Insulin increases renal magnesium excretion: a possible cause of


magnesium

depletion

in

hyperinsulinaemic

states.

Diabet

Med.

1995;12:664669.
71)

McNair P, Christensen MS, Christiansen C, Madsbad S, Transbl I.

Renal hypomagnesaemia in human diabetes mellitus: its relation to


glucose homeostasis. Eur J Clin Invest. 1982;12:8185.
72)

Lee CT, Lien YH, Lai LW, Chen JB, Lin CR, Chen HC. Increased renal

calcium and magnesium transporter abundance in streptozotocininduced diabetes mellitus. Kidney Int. 2006;69:17861791.
73)

Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G.

Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus


is not corrected by improvement of long-term metabolic control.
Diabetologia. 1992;35:7779.
74)

Wang J, Persuitte G, Olendzki B, Wedick N, Zhang Z, Merriam P et al.

Dietary Magnesium Intake Improves Insulin Resistance among NonDiabetic Individuals with Metabolic Syndrome Participating in a Dietary
Trial. 2016.
75)

Hruby A, Meigs J, ODonnell C, Jacques P, McKeown N. Higher

magnesium intake reduces risk of impaired glucose and insulin


metabolism, and progression from prediabetes to diabetes in middleaged

Americans

[Internet].

Care.diabetesjournals.org.

2016[cited4November2016].Availablefrom:
http://care.diabetesjournals.org/content/early/2013/09/23/dc131397.short.
76)

Jinsong

Wang, Gioia

Persuitte, Barbara

Olendzki, Nicole

Wedick, Zhiying Zhang, Philip Merriam, Hua Fang, James Carmody, GinFei Olendzki, Yunsheng Ma, Dietary Magnesium Intake Improves Insulin
Resistance among Non-Diabetic Individuals with Metabolic Syndrome
Participating in a Dietary Trial, Nutrients, 2013, 5, 10, 3910

77)

Rumawas ME e. Magnesium intake is related to improved insulin

homeostasis in the framingham offspring cohort. - PubMed - NCBI


[Internet]. Ncbi.nlm.nih.gov. 2016 [cited 4 November 2016]. Available
from: https://www.ncbi.nlm.nih.gov/pubmed/17229895.
78)

K. Wltia, M. Low plasma magnesium in type 2 diabetes. SWISS

MED WKLY. 2003;(1 3 3): 2 8 9 2 9 2.


79)

Kashinkunti M. A Cross Sectional Study of Fasting Serum

Magnesium Levels in the Patients with Type 2 Diabetes Mellitus and Its
Relation to Diabetic Complications. Scholars Journal of Applied Medical
Sciences (SJAMS). 2014;(2(2A):502-506.
80)

Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2

diabetes mellitus. Indian J Endocr Metab 2012;16:1000-3.


81)

Kauser M.M Study of serum magnesium in type 2 Diabetes Mellitus

and its correlation with the modality of treatment- A south Indian study.
International Journal of Biomedical And Advance Research [Internet].
2016 [cited 8 May 2014];. Available from: http://www.ssjournals.com.
82)

El-said NH, Sadik NA, ELGhaffar Mohammed NA. Magnesium in type

2 diabetes mellitus and its correlation with glycemic control. Int J Res
Med Sci 2015;3(8):1958-63.
83)

Resnick LM, Gupta RK, Gruenspan H, Laragh JH: Intracellular free

magnesium in hypertension: Relation to peripheral insulin resistance. J


Hypertens 6[Suppl 4]: s199s201, 1988.
84)

Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a

risk factor for coronary heart disease? The Atherosclerosis Risk in


Communities (ARIC) Study. Am Heart J 136: 480490, 1998.
85)

McNair P, Christiansen C, Modibad S, Binder C: Hypomagnesemia, a

risk factor in diabetic retinopathy. Diabetes 27: 10751077, 1978.


86)

Hatwal A, Gujral AS, Bhatia RPS, Agrawal JK, Bajpai HS: Association

of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol 67:


714716, 1989.

87)

Corsonello A, Lentile R, Buemi M, Cucinotta D, Mauro VN, Macaione

S, Corica F: Serum ionized magnesium levels in type 2 diabetic patients


with microalbuminuria or clinical proteinuria. Am J Nephrol 20: 187
192, 2000.
88)

Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM,

Yanagawa N, Pham PT: Lower serum magnesium levels are associated


with more rapid decline of renal function in patients with diabetes
mellitus type 2. Clin Nephrol 63: 429436, 2005 [published erratum
appears in Clin Nephrol 64: 248, 2005].
89)

Sales CR, de Fatima Campos Pedrosa L: Magnesium and diabetes

mellitus: Their relation. Clin Nutr 25: 554562, 2006.


90)

Mamatha B. A COMPARATIVE STUDY OF SERUM MAGNESIUM IN TYPE

2 DIABETES MELLITUS PATIENTS AND NON DIABETICS AND ITS


CORRELATION

WITH

GLYCEMIC

STATUS.

International

Journal

of

Bioassays. 2014;3(10):3395-3398.
91)

Dipankar

Kundu,

Manish

Osta,

Tridibeswar

Mandal,

Ujjwal

Bandyopadhyay, Debes Ray, Divyendu Gautam, J Nat Sci Biol Med.


2013 Jan-Jun; 4(1): 113116. doi: 10.4103/0976-9668.107270.